Dr. Jack A. Klapper

Psychiatry
Office
1155 E 18th Ave, 
Denver, CO 
Office
1155 E 18th Ave, 
Denver, CO 

Overview

Jack Klapper is a Psychiatrist practicing medicine in Denver, Colorado.

His clinical expertise encompasses Alzheimer's Disease and Dementia.

He is actively involved in clinical research, participating in 9 clinical trials.

Specialties

Psychiatry

Licenses

Specialist in CO

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Office
1155 E 18th Ave, Denver, CO 80218

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
Enrollment Status: Completed
Publish Date: November 10, 2025
Intervention Type: Drug
Study Drug: ALZ-801
Study Phase: Phase 3
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2/Phase 3
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drug: BPN14770
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 19, 2024
Intervention Type: Drug
Study Drug: T3D-959
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of AGB101on Slowing Progression of Mild Cognitive Impairment Due to Alzheimer's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of AGB101on Slowing Progression of Mild Cognitive Impairment Due to Alzheimer's Disease
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Drug
Study Drug: AGB101
Study Phase: Phase 2/Phase 3
A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)
A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 3
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Enrollment Status: Completed
Publish Date: October 24, 2018
Intervention Type: Drug
View 8 Less Clinical Trials
Similar Doctors
Expertise in
2
conditions
Expertise in
2
conditions
Referral may be required

University Of Colorado

13001 E 17th Pl, 
Aurora, CO 
 (7.2 miles away)
303-724-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Cynthia Epperson is a Psychiatrist practicing medicine in Aurora, Colorado. Dr. Epperson is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Postpartum Depression, Menopause, Post-Traumatic Stress Disorder (PTSD), Major Depression, and Hormone Replacement Therapy (HRT). Dr. Epperson is currently accepting new patients.

Expertise in
7
conditions
Expertise in
7
conditions
Referral may be required

Mary G Heyrosa MD LLC

757 E 20th Ave Ste 370, 
Denver, CO 
 (1.1 miles away)
720-239-2280
Languages Spoken:
English
See accepted insurances

Michael Fuller is a Psychiatrist practicing medicine in Denver, Colorado. Dr. Fuller is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Schizoaffective Disorder, Bipolar Disorder (BPD), Major Depression, and Seasonal Affective Disorder (SAD).

Expertise in
1
conditions
Expertise in
1
conditions
Referral may be required

University Of Colorado

13001 E 17th Pl, 
Aurora, CO 
 (7.2 miles away)
303-724-6018
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Randi Libbon is a Psychiatrist practicing medicine in Aurora, Colorado. Dr. Libbon is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Conversion Disorder and Post-Traumatic Stress Disorder (PTSD). Dr. Libbon is currently accepting new patients.

Frequently Asked Questions about Dr. Jack A. Klapper

How do I make an appointment with Dr. Jack A. Klapper?

You can book an appointment with Dr. Jack A. Klapper by calling their office at 303-839-9900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jack A. Klapper a top-rated expert for Alzheimer's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jack A. Klapper is classified as an Experienced expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jack A. Klapper specialize in?

While Dr. Jack A. Klapper is a Psychiatry, they have specific expertise in Alzheimer's Disease, Dementia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Jack A. Klapper accept my insurance?

Dr. Jack A. Klapper accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 303-839-9900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Klapper's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile